CAMBRIDGE, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing ...

Leerink Partners has recently raised Beam Therapeutics Inc (BEAM) stock to Outperform rating, as announced on November 6, 2024, according to Finviz. Earlier, on October 16, 2024, Scotiabank had ...

SMid Biotech Analyst Joseph holds a conference call with CEO Evans on November 12 at 2 pm hosted by JPMorgan.Webcast Link Published first on ...

Check the time stamp on this data. Updated AI-Generated Signals for Beam Therapeutics Inc. (BEAM) available here: BEAM.

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

It has been around a year since Beam Therapeutics slashed its headcount and R&D programmes to focus mainly on a sickle cell disease candidate – and the biotech has now revealed the first data ...

A Mayo Clinic research team tested a shorter radiation treatment plan on breast cancer patients. The abbreviated treatment ...

Cathie Wood's ARK Innovation ETF (ARKK) has surged to its highest trading level in more than two years this week, surpassing ...

CGN Nuclear Technology Development, a subsidiary of China General Nuclear Power Group (CGN), recently announced that it ...

A combination of ultrahigh-dose rate electron and conventional photon radiotherapy could enable FLASH treatments of ...

Through partnership with Legion Healthcare Partners, proton therapy system will target tumors without "exit radiation" ...